News
Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results